[go: up one dir, main page]

GB201114289D0 - Flurbiprofen and related compounds for the treatment of skin diseases - Google Patents

Flurbiprofen and related compounds for the treatment of skin diseases

Info

Publication number
GB201114289D0
GB201114289D0 GBGB1114289.0A GB201114289A GB201114289D0 GB 201114289 D0 GB201114289 D0 GB 201114289D0 GB 201114289 A GB201114289 A GB 201114289A GB 201114289 D0 GB201114289 D0 GB 201114289D0
Authority
GB
United Kingdom
Prior art keywords
flurbiprofen
treatment
related compounds
skin diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1114289.0A
Other versions
GB2493914A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goethe Universitaet Frankfurt am Main
Original Assignee
Goethe Universitaet Frankfurt am Main
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goethe Universitaet Frankfurt am Main filed Critical Goethe Universitaet Frankfurt am Main
Priority to GB1114289.0A priority Critical patent/GB2493914A/en
Publication of GB201114289D0 publication Critical patent/GB201114289D0/en
Priority to PCT/EP2012/066034 priority patent/WO2013026772A1/en
Publication of GB2493914A publication Critical patent/GB2493914A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1114289.0A 2011-08-19 2011-08-19 Flurbiprofen and related compounds for the treatment of skin diseases Withdrawn GB2493914A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1114289.0A GB2493914A (en) 2011-08-19 2011-08-19 Flurbiprofen and related compounds for the treatment of skin diseases
PCT/EP2012/066034 WO2013026772A1 (en) 2011-08-19 2012-08-16 Flurbiprofen and related compounds for the treatment of skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1114289.0A GB2493914A (en) 2011-08-19 2011-08-19 Flurbiprofen and related compounds for the treatment of skin diseases

Publications (2)

Publication Number Publication Date
GB201114289D0 true GB201114289D0 (en) 2011-10-05
GB2493914A GB2493914A (en) 2013-02-27

Family

ID=44800539

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1114289.0A Withdrawn GB2493914A (en) 2011-08-19 2011-08-19 Flurbiprofen and related compounds for the treatment of skin diseases

Country Status (2)

Country Link
GB (1) GB2493914A (en)
WO (1) WO2013026772A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017066074A (en) * 2015-09-30 2017-04-06 三笠製薬株式会社 Atopic dermatitis therapeutic agent
WO2017080989A1 (en) 2015-11-09 2017-05-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (r)-fluriprofen for the prevention and/or treatment of diabetes
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
KR102718287B1 (en) 2017-11-14 2024-10-16 머크 샤프 앤드 돔 엘엘씨 Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2035085B (en) * 1978-11-08 1983-03-02 Upjohn Ltd Cycloheximide or an analogue thereof compositions
JPH09504018A (en) * 1993-10-20 1997-04-22 ザ ブーツ カンパニー ピーエルシー Ibuprofen and flurbiprofen as antipruritic agents
US5807568A (en) 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
US20030143165A1 (en) * 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
GB2474748B (en) * 2009-10-01 2011-10-12 Amira Pharmaceuticals Inc Polycyclic compounds as lysophosphatidic acid receptor antagonists
EP2468270A1 (en) * 2010-12-21 2012-06-27 GALENpharma GmbH (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases

Also Published As

Publication number Publication date
WO2013026772A1 (en) 2013-02-28
GB2493914A (en) 2013-02-27

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for the treatment of tissue
EP2621499A4 (en) Methods for the treatment of allergic diseases
AP2014007533A0 (en) Substituted benzylindazoles for use as BUB1 kinaseinhibitors in the treatment of hyperproliferative diseases
GB2524689B (en) Cannabinoids for use in the treatment of neuropathic pain
ZA201308111B (en) Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
PL2925757T3 (en) Compounds and compositions for the treatment of parasitic diseases
IL226049A0 (en) A compound for use in the prevention and/or treatment of skin conditions and skin diseases
ZA201301601B (en) Treatment of diseases
ZA201304822B (en) Azetidine derivatives useful for the treatment of metabolic and inflimmatory diseases
EP2718255A4 (en) CHINONIC COMPOUNDS FOR THE TREATMENT OF APE1-MEDIATED DISEASES
EP2709632A4 (en) Compositions and methods for the treatment of skin diseases
ZA201208389B (en) Treatment of proliferative diseases
IL275636A (en) Therapeutic combination for the treatment of cancer
PL2731584T3 (en) Use of oligosaccharide compounds for the prevention and treatment of pathological scars
GB201114289D0 (en) Flurbiprofen and related compounds for the treatment of skin diseases
HUE055818T2 (en) Devices for the treatment of skin lesions
IL234796B (en) Compounds for the treatment of ischemia-reperfusion-related diseases
EP2776020A4 (en) Methods for the treatment of skin neoplasms
PT2456445E (en) Agent for the treatment of skin conditions
GB201010638D0 (en) Composition for treatment of skin
AU2011903764A0 (en) Treatment of bone diseases
AU2011902407A0 (en) Treatment of pain
IL204097A0 (en) Medicine for the treatment of skin cancer
IL232294A0 (en) Formulations for the treatment of diabetes
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)